BLFSNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

BIOLIFE SOLUTIONS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$38.61+0.00 (0.00%)

Close on Oct 7, 2026

Community

Notes and questions about Biolife Solutions from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Biolife Solutions's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-14 reverse split on Feb 12, 2014
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BLFS.

Revenue growth25.4% · median 15.3%

Gross margin60.4% · median 74.6%

Operating margin2.9% · median -2.0%

Net margin56.4% · median 3.1%

Advertisement
300 × 250